Brazil: revenue of pharma companies in 2019
The Brazilian company Aché Laboratórios Farmacêuticos S.A. was the leading pharmaceutical company in Brazil in 2019, with a revenue of 4.24 billion Brazilian reals. Brazilian EMS Pharma S.A. ranked second with a revenue of 3.67 billion reals. The total revenue of the pharmaceutical market in Brazil reached more than 102 billion reals in 2019, a value that has been constantly increasing since 2015.
Brazil in the global pharmaceutical market
Brazil was among the leading pharmaceutical markets worldwide in 2019, with a market share of around 2.2 percent. The market is mostly dominated by sales of new medicines and biologicals, which comprise more than 40 percent of the revenue. Generic drugs, in comparison, accounted for only 13 percent of it.
Brazilian pharmaceutical industry
The manufacturing industry is one of the main sectors of Brazil’s economy, and makes up approximately 9.4 percent of the country’s gross domestic product. The pharmaceutical segment is no exception: with a production value of more than 41 billion Brazilian reals in 2018, the drug production market employed more than 194 thousand people. For instance, only in the wholesale segment, the pharma sector was responsible for 10.2 billion Brazilian reals spent on salaries and remuneration.
Brazil in the global pharmaceutical market
Brazil was among the leading pharmaceutical markets worldwide in 2019, with a market share of around 2.2 percent. The market is mostly dominated by sales of new medicines and biologicals, which comprise more than 40 percent of the revenue. Generic drugs, in comparison, accounted for only 13 percent of it.
Brazilian pharmaceutical industry
The manufacturing industry is one of the main sectors of Brazil’s economy, and makes up approximately 9.4 percent of the country’s gross domestic product. The pharmaceutical segment is no exception: with a production value of more than 41 billion Brazilian reals in 2018, the drug production market employed more than 194 thousand people. For instance, only in the wholesale segment, the pharma sector was responsible for 10.2 billion Brazilian reals spent on salaries and remuneration.
